Ethylisopropyltryptamine

Ethylisopropyltryptamine

Clinical data
ATC code	none
Legal status
Legal status	DE: NpSG (Industrial and scientific use only) UK: Class A
Identifiers
IUPAC name N-ethyl-N-[2-(1H-indol-3-yl)ethyl]propan-2-amine
CAS Number	848130-11-0 Y
ChemSpider	21106305 Y
UNII	63J8CXV5Z8
Chemical and physical data
Formula	C15H22N2
Molar mass	230.355 g·mol−1
3D model (JSmol)	Interactive image
Melting point	71 to 73 °C (160 to 163 °F)
SMILES CCN(C(C)C)CCc1c[nH]c2ccccc12
InChI InChI=1S/C15H22N2/c1-4-17(12(2)3)10-9-13-11-16-15-8-6-5-7-14(13)15/h5-8,11-12,16H,4,9-10H2,1-3H3 Y Key:HQZLBYMOYCJZRF-UHFFFAOYSA-N Y
(verify)

Ethylisopropyltryptamine (EiPT) is a chemical of the tryptamine family that and produces psychedelic and hallucinogenic effects. It was probably first synthesized by American psychopharmacologist, Alexander Shulgin.

EiPT is short for N-ethyl-N-isopropyl-tryptamine. The full chemical name of this structure is N-ethyl-N-[2-(1H-indol-3-yl)ethyl]propan-2-amine. EiPT is a tryptamine, which all belong to a larger family of compounds known as indolethylamines. EiPT is closely related to the compounds diethyltryptamine (DET) and DIPT.

In his book TiHKAL, Alexander Shulgin lists a dosage for EiPT as being 24-40 mg taken orally.

Very little is known about the psychopharmacological properties of EiPT, but reports suggest it produces psychedelic effects that can last 4–6 hours. According to Shulgin, this compound tends to produce nausea, dysphoria, and other unpleasant side-effects. It also lacks the hallucinatory and visual properties usually associated with psychedelic drugs.

There have been no reported deaths or hospitalizations from EiPT, but its safety profile is unknown.

EiPT is unscheduled and uncontrolled in the United States, but possession and sales of EiPT could be prosecuted under the Federal Analog Act because of its structural similarities to DET.

• 5-MeO-EiPT

• EiPT entry from TiHKAL
• EiPT entry in TiHKAL • info